Lista de obras - Daniel Kirby - Dominio Público Uruguay

A Holistic Multi Evidence Approach to Study the Fragmentation Behaviour of Crystalline Mannitol

artículo científico publicado en 2015

A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice

artículo científico publicado en 2006

A pragmatic approach for engineering porous mannitol and mechanistic evaluation of particle performance.

artículo científico publicado en 2015

Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability.

artículo científico publicado en 2017

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus.

artículo científico publicado en 2018

Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses

artículo científico publicado en 2005

Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets

artículo científico publicado en 2019

Developing solid particulate vaccine adjuvants: surface bound antigen favours a humoural response, whereas entrapped antigen shows a tendency for cell mediated immunity

artículo científico publicado en 2013

Does the Formulation of Oral Solid Dosage Forms Affect Acceptance and Adherence in Older Patients? A Mixed Methods Systematic Review

scientific article published on 26 March 2020

Environmental Scanning Electron Microscope Imaging of Vesicle Systems.

artículo científico publicado en 2017

Environmental scanning electron microscope imaging of vesicle systems.

artículo científico publicado en 2010

Formulation design considerations for oral vaccines.

artículo científico

Inappropriate oral formulations and information in paediatric trials.

artículo científico publicado en 2010

Increased potential of a cationic liposome-based delivery system: enhancing stability and sustained immunological activity in pre-clinical development

artículo científico publicado en 2010

Liposome-based cationic adjuvant formulations (CAF): past, present, and future

artículo científico publicado en 2009

Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres

artículo científico publicado en 2008

Liposomes: a promising carrier for respiratory syncytial virus therapeutics

artículo científico publicado en 2019

Manipulation of the surface pegylation in combination with reduced vesicle size of cationic liposomal adjuvants modifies their clearance kinetics from the injection site, and the rate and type of T cell response

artículo científico publicado en 2012

Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs

artículo científico publicado en 2016

Nonaqueous capillary zone electrophoresis of synthetic organic polypeptides.

artículo científico publicado en 2003

Noncovalent coatings for the separation of synthetic polypeptides by nonaqueous capillary electrophoresis

artículo científico publicado en 2005

PLGA microspheres for the delivery of a novel subunit TB vaccine

artículo científico publicado en 2008

Patient-Centric Medicine Design: Key Characteristics of Oral Solid Dosage Forms that Improve Adherence and Acceptance in Older People

scientific article published on 23 September 2020

Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses

scientific article published on 18 October 2011

Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent.

artículo científico publicado en 2010

The application of monolayer studies in the understanding of liposomal formulations.

artículo científico publicado en 2011

The impact of ageing on the barriers to drug delivery.

artículo científico publicado en 2012

The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs.

artículo científico publicado en 2012

Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens

artículo científico publicado en 2008

alpha,alpha'-trehalose 6,6'-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-drying

artículo científico publicado en 2008

Lista de obras de Daniel Kirby

A Holistic Multi Evidence Approach to Study the Fragmentation Behaviour of Crystalline Mannitol

A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice

A pragmatic approach for engineering porous mannitol and mechanistic evaluation of particle performance.

Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability.

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus.

Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses

Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets

Developing solid particulate vaccine adjuvants: surface bound antigen favours a humoural response, whereas entrapped antigen shows a tendency for cell mediated immunity

Does the Formulation of Oral Solid Dosage Forms Affect Acceptance and Adherence in Older Patients? A Mixed Methods Systematic Review

Environmental Scanning Electron Microscope Imaging of Vesicle Systems.

Environmental scanning electron microscope imaging of vesicle systems.

Formulation design considerations for oral vaccines.

Inappropriate oral formulations and information in paediatric trials.

Increased potential of a cationic liposome-based delivery system: enhancing stability and sustained immunological activity in pre-clinical development

Liposome-based cationic adjuvant formulations (CAF): past, present, and future

Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres

Liposomes: a promising carrier for respiratory syncytial virus therapeutics

Manipulation of the surface pegylation in combination with reduced vesicle size of cationic liposomal adjuvants modifies their clearance kinetics from the injection site, and the rate and type of T cell response

Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs

Nonaqueous capillary zone electrophoresis of synthetic organic polypeptides.

Noncovalent coatings for the separation of synthetic polypeptides by nonaqueous capillary electrophoresis

PLGA microspheres for the delivery of a novel subunit TB vaccine

Patient-Centric Medicine Design: Key Characteristics of Oral Solid Dosage Forms that Improve Adherence and Acceptance in Older People

Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses

Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent.

The application of monolayer studies in the understanding of liposomal formulations.

The impact of ageing on the barriers to drug delivery.

The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs.

Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens

alpha,alpha'-trehalose 6,6'-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-drying